Cargando…

Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR

HIV-1 is transcriptionally active in activated T helper (Th)-cells and inactive in naive or resting memory Th-cells. Ets-2 is a preinduction transcriptional repressor of the IL-2 gene in naive Th-cells and a candidate transcriptional repressor of HIV-1 in the same cells, because the −279 to −250 ups...

Descripción completa

Detalles Bibliográficos
Autores principales: Panagoulias, Ioannis, Karagiannis, Fotios, Aggeletopoulou, Ioanna, Georgakopoulos, Tassos, Argyropoulos, Christos P., Akinosoglou, Karolina, Gogos, Charalambos, Skoutelis, Athanasios, Mouzaki, Athanasia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758550/
https://www.ncbi.nlm.nih.gov/pubmed/29354130
http://dx.doi.org/10.3389/fimmu.2017.01924
_version_ 1783291011706912768
author Panagoulias, Ioannis
Karagiannis, Fotios
Aggeletopoulou, Ioanna
Georgakopoulos, Tassos
Argyropoulos, Christos P.
Akinosoglou, Karolina
Gogos, Charalambos
Skoutelis, Athanasios
Mouzaki, Athanasia
author_facet Panagoulias, Ioannis
Karagiannis, Fotios
Aggeletopoulou, Ioanna
Georgakopoulos, Tassos
Argyropoulos, Christos P.
Akinosoglou, Karolina
Gogos, Charalambos
Skoutelis, Athanasios
Mouzaki, Athanasia
author_sort Panagoulias, Ioannis
collection PubMed
description HIV-1 is transcriptionally active in activated T helper (Th)-cells and inactive in naive or resting memory Th-cells. Ets-2 is a preinduction transcriptional repressor of the IL-2 gene in naive Th-cells and a candidate transcriptional repressor of HIV-1 in the same cells, because the −279 to −250 upstream region of HIV-1-LTR [repressor–activator target sequence (RATS)], that participates in HIV-1-LTR transcriptional silencing, encompasses the AAGGAG Ets-2 binding site. In this proof of concept study, we investigated whether Ets-2 represses the expression of HIV-1. To assess whether Ets-2 can repress HIV-1 transcriptional activation acting through RATS, we transfected Jurkat cells with an Ets-2 overexpression plasmid (pCDNA3-ets-2) or Ets-2 silencing plasmids (ets-2-shRNA) and, as target genes, plasmids carrying the whole HIV-1-LTR sequence (HIV-1-LTR-CAT) or two copies of the RATS sequence (2× RATS-CAT) or a point mutation in the Ets-2 binding site (2× mutantRATS-CAT) or CMV-CAT (control). Ets-2 overexpression resulted in a significant reduction of HIV-1-LTR-CAT and 2× RATS-CAT activities in stimulated cells, but not of the 2× mutantRATS-CAT or CMV-CAT. Ets-2 silencing led to increased activities of HIV-1-LTR-CAT and 2× RATS-CAT in unstimulated cells, but had no effect on the activities of 2× mutantRATS-CAT and CMV-CAT. To assess Ets-2 binding to HIV-1-LTR–RATS in naive Th-cells, we isolated naive Th-cell nuclear proteins and passed them through an Ets-2 antibody column; electrophoretic mobility shift assays were performed using an RATS probe mixed with consecutive protein eluates. Ets-2 bound to the HIV-1-LTR–RATS in a dose-dependent manner. To assess Ets-2 binding to RATS in vivo, Jurkat cells were transfected with 2× RATS-CAT and stained for the Ets-2 protein and the RATS sequence by combining immunofluorescence and fluorescence in situ hybridization techniques. In unstimulated cells, Ets-2 bound to RATS, whereas no binding was observed in stimulated cells. To test for RATS specificity, the same experiments were performed with 2× mutantRATS-CAT, and no binding of Ets-2 was observed. The results were corroborated by chromatin immunoprecipitation assays performed with the same cells. Our results show that Ets-2 is a transcriptional repressor of HIV-1. Repression of HIV-LTR-RATS mediated by Ets-2 may account for the low-level transcription and replication of HIV-1 in naive Th-cells, and contribute to the viral latency and maintenance of viral reservoirs in patients, despite long-term therapy.
format Online
Article
Text
id pubmed-5758550
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-57585502018-01-19 Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR Panagoulias, Ioannis Karagiannis, Fotios Aggeletopoulou, Ioanna Georgakopoulos, Tassos Argyropoulos, Christos P. Akinosoglou, Karolina Gogos, Charalambos Skoutelis, Athanasios Mouzaki, Athanasia Front Immunol Immunology HIV-1 is transcriptionally active in activated T helper (Th)-cells and inactive in naive or resting memory Th-cells. Ets-2 is a preinduction transcriptional repressor of the IL-2 gene in naive Th-cells and a candidate transcriptional repressor of HIV-1 in the same cells, because the −279 to −250 upstream region of HIV-1-LTR [repressor–activator target sequence (RATS)], that participates in HIV-1-LTR transcriptional silencing, encompasses the AAGGAG Ets-2 binding site. In this proof of concept study, we investigated whether Ets-2 represses the expression of HIV-1. To assess whether Ets-2 can repress HIV-1 transcriptional activation acting through RATS, we transfected Jurkat cells with an Ets-2 overexpression plasmid (pCDNA3-ets-2) or Ets-2 silencing plasmids (ets-2-shRNA) and, as target genes, plasmids carrying the whole HIV-1-LTR sequence (HIV-1-LTR-CAT) or two copies of the RATS sequence (2× RATS-CAT) or a point mutation in the Ets-2 binding site (2× mutantRATS-CAT) or CMV-CAT (control). Ets-2 overexpression resulted in a significant reduction of HIV-1-LTR-CAT and 2× RATS-CAT activities in stimulated cells, but not of the 2× mutantRATS-CAT or CMV-CAT. Ets-2 silencing led to increased activities of HIV-1-LTR-CAT and 2× RATS-CAT in unstimulated cells, but had no effect on the activities of 2× mutantRATS-CAT and CMV-CAT. To assess Ets-2 binding to HIV-1-LTR–RATS in naive Th-cells, we isolated naive Th-cell nuclear proteins and passed them through an Ets-2 antibody column; electrophoretic mobility shift assays were performed using an RATS probe mixed with consecutive protein eluates. Ets-2 bound to the HIV-1-LTR–RATS in a dose-dependent manner. To assess Ets-2 binding to RATS in vivo, Jurkat cells were transfected with 2× RATS-CAT and stained for the Ets-2 protein and the RATS sequence by combining immunofluorescence and fluorescence in situ hybridization techniques. In unstimulated cells, Ets-2 bound to RATS, whereas no binding was observed in stimulated cells. To test for RATS specificity, the same experiments were performed with 2× mutantRATS-CAT, and no binding of Ets-2 was observed. The results were corroborated by chromatin immunoprecipitation assays performed with the same cells. Our results show that Ets-2 is a transcriptional repressor of HIV-1. Repression of HIV-LTR-RATS mediated by Ets-2 may account for the low-level transcription and replication of HIV-1 in naive Th-cells, and contribute to the viral latency and maintenance of viral reservoirs in patients, despite long-term therapy. Frontiers Media S.A. 2018-01-04 /pmc/articles/PMC5758550/ /pubmed/29354130 http://dx.doi.org/10.3389/fimmu.2017.01924 Text en Copyright © 2018 Panagoulias, Karagiannis, Aggeletopoulou, Georgakopoulos, Argyropoulos, Akinosoglou, Gogos, Skoutelis and Mouzaki. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Panagoulias, Ioannis
Karagiannis, Fotios
Aggeletopoulou, Ioanna
Georgakopoulos, Tassos
Argyropoulos, Christos P.
Akinosoglou, Karolina
Gogos, Charalambos
Skoutelis, Athanasios
Mouzaki, Athanasia
Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR
title Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR
title_full Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR
title_fullStr Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR
title_full_unstemmed Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR
title_short Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR
title_sort ets-2 acts as a transcriptional repressor of the human immunodeficiency virus type 1 through binding to a repressor–activator target sequence of 5′-ltr
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758550/
https://www.ncbi.nlm.nih.gov/pubmed/29354130
http://dx.doi.org/10.3389/fimmu.2017.01924
work_keys_str_mv AT panagouliasioannis ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr
AT karagiannisfotios ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr
AT aggeletopoulouioanna ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr
AT georgakopoulostassos ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr
AT argyropouloschristosp ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr
AT akinosogloukarolina ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr
AT gogoscharalambos ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr
AT skoutelisathanasios ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr
AT mouzakiathanasia ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr